Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Return on Capital Employed: 2019-2025

Historic Return on Capital Employed for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to -0.35%.

  • Neurogene's Return on Capital Employed rose 14.00% to -0.35% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.35%, marking a year-over-year increase of 14.00%. This contributed to the annual value of -0.31% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Neurogene's Return on Capital Employed is -0.35%, which was down 6.45% from -0.33% recorded in Q2 2025.
  • Neurogene's 5-year Return on Capital Employed high stood at -0.29% for Q1 2025, and its period low was -1.02% during Q2 2023.
  • In the last 3 years, Neurogene's Return on Capital Employed had a median value of -0.39% in 2024 and averaged -0.46%.
  • Data for Neurogene's Return on Capital Employed shows a peak YoY skyrocketed of 63bps (in 2024) over the last 5 years.
  • Neurogene's Return on Capital Employed (Quarterly) stood at -0.42% in 2023, then rose by 7bps to -0.35% in 2024, then grew by 14bps to -0.35% in 2025.
  • Its last three reported values are -0.35% in Q3 2025, -0.33% for Q2 2025, and -0.29% during Q1 2025.